Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on French Industry Network.
Press releases published on April 30, 2025
Fusion energy: ITER completes world’s largest and most powerful pulsed magnet system
EIN Presswire
·
April 30, 2025
Landmark achievement towards fusion energy SAINT-PAUL-LEZ-DURANCE, FRANCE, April 30, 2025 /EINPresswire.com/ -- In a landmark achievement for fusion energy, ITER has completed all components for the world’s largest, most powerful pulsed superconducting …
Keolis MHI Drives Collective Action During Sustainability Week 2025, Aligning with UAE’s Green Agenda
EIN Presswire
·
April 30, 2025
DUBAI, UNITED ARAB EMIRATES, April 30, 2025 /EINPresswire.com/ -- Keolis MHI successfully concluded its annual Sustainability Week (April 21–25, 2025) under the banner of the “Keolis MHI Way”, reinforcing its commitment to environmental guardianship and …
Information relative au nombre total de droits de vote et d’actions composant le capital social au 11 avril 2025
GlobeNewswire
·
April 30, 2025
Article R. 22-10-23 du Code de commerce Place de cotation : Euronext Paris Code ISIN / Mnémo : FR0013233012 / IVA Site web : www.inventivapharma.com Date Nombre de titres composant le capital en circulation Nombre total de droits de vote bruts(1) …
Statement of total voting rights and shares forming the company’s share capital as of April 11, 2025
GlobeNewswire
·
April 30, 2025
Article R. 22-10-23 of the French Commercial Code Market: Euronext Paris ISIN code / Mnemo: FR0013233012 / IVA Web site: www.inventivapharma.com Date Number of shares outstanding Total voting rights, gross (1) Total voting rights, net (2) April 11, 2025 95 …
Combined General Meeting of May 22, 2025 - Availability of the preparatory documents
GlobeNewswire
·
April 30, 2025
Daix (France), New York City (New York, United States), April 30, 2025 – Inventiva (Euronext Paris and Nasdaq: IVA), a clinical-stage biopharmaceutical company focused on the development of oral small molecule therapies for the treatment of metabolic …
DBV Technologies Reports First Quarter 2025 Financial Results
GlobeNewswire
·
April 30, 2025
Châtillon, France, April 30, 2025 DBV Technologies Reports First Quarter 2025 Financial Results DBV Technologies (Euronext: DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT – CUSIP: 23306J309), a clinical-stage biopharmaceutical company, today …
DBV Technologies publie ses résultats financiers du 1er trimestre 2025
GlobeNewswire
·
April 30, 2025
Châtillon, France, le 30 avril (22 :00 CEST) 2025 DBV Technologies publie ses résultats financiers du 1er trimestre 2025 DBV Technologies (Euronext : DBV - ISIN : FR0010417345 - Nasdaq Stock Market : DBVT-CUSIP :23306J309), société biopharmaceutique au …
Assemblée Générale Mixte du 22 mai 2025 - Modalités de mise à disposition des documents préparatoires
GlobeNewswire
·
April 30, 2025
Daix (France), New York City (New York, Etats-Unis), le 30 avril 2025 – Inventiva (Euronext Paris et NASDAQ : IVA) (« Inventiva » ou la « Société »), société biopharmaceutique spécialisée dans le développement clinique de petites molécules administrées par …
TSplus International Meeting 2025 Took Place in Bali
GlobeNewswire
·
April 30, 2025
LYON, France, April 30, 2025 (GLOBE NEWSWIRE) -- From April 14–18, TSplus hosted its annual International Meeting in Bali, Indonesia—bringing together more than 100 collaborators and their families from around the world. This major event combined …
Convening of the Annual General Meeting to approve the 2024 financial statements to be held on June 13, 2025 and evolution of the Atos Board of Directors
GlobeNewswire
·
April 30, 2025
Press Release Convening of the Annual General Meeting to approve the 2024 financial statements to be held on June 13, 2025 and evolution of the Atos Board of Directors Paris, France – April 30, 2025 Convening of the 2025 Annual General Meeting The meeting …
Convocation de l’Assemblée Générale Annuelle d’approbation des comptes 2024 prévue le 13 juin 2025 et évolution du Conseil d’administration d’Atos
GlobeNewswire
·
April 30, 2025
Communiqué de presse Convocation de l’Assemblée Générale Annuelle d’approbation des comptes 2024 prévue le 13 juin 2025 et évolution du Conseil d’administration d’Atos Paris, France – 30 avril 2025 Convocation de l’Assemblée Générale Annuelle de 2025 L’ …
Press Release: Annual General Meeting of April 30, 2025
GlobeNewswire
·
April 30, 2025
Annual General Meeting of April 30, 2025 Approval of the financial statements for the fiscal year 2024 Distribution of a cash dividend of €3.92 per share, with payment as of May 14, 2025 Board composition: renewal of four Directors and ratification of the …
Communiqué de presse : Assemblée Générale Annuelle du 30 avril 2025
GlobeNewswire
·
April 30, 2025
Assemblée Générale Annuelle du 30 avril 2025 Approbation des comptes sociaux et des comptes consolidés de l’exercice 2024 Distribution d’un dividende en numéraire de 3,92 euros par action, dont la mise en paiement interviendra le 14 mai 2025 Composition du …
AKWEL: TURNOVER FOR THE FIRST QUARTER OF 2025
GlobeNewswire
·
April 30, 2025
Champfromier, Wednesday, April 30, 2025 TURNOVER FOR THE FIRST QUARTER OF 2025 AKWEL (FR0000053027, AKW, PEA-eligible), parts and systems manufacturer for the automotive and heavy-vehicle industry, specialist in fluid management, mechanisms and …
AKWEL: 2025 年第一季度营业额
GlobeNewswire
·
April 30, 2025
尚夫罗米耶，2025 年 4 月 30 日星期三 2025 年第一季度营业额 AKWEL（FR0000053027，AKW，符合 PEA 资格）是汽车和重型货车行业的系统设备制造商，专注于电动汽车的流体、机械和结构部件管理，在 2025 年第一季度综合营业额达 2.556 亿欧元。 2025 年第一季度综合营业额 （1 月 1 日至 3 月 31 日） 单位：百万欧元 - 未经审计 2025 2024 变化 在汇率不变基础上同比变化 (*) 第一季度 255.6 263.5 -3 …
ASSYSTEM : First-quarter 2025 consolidated revenue
GlobeNewswire
·
April 30, 2025
First-quarter 2025 consolidated revenue: €166.3m (up 7.8%) Organic growth: 3.5% vs Q1 2024 2024 dividend payment calendar Paris La Défense, 30 April 2025, 5.35 p.m. (CEST) – The Board of Directors of Assystem S.A. (ISIN: FR0000074148 - ASY), an …
ASSYSTEM : Chiffre d'affaires du 1er trimestre 2025
GlobeNewswire
·
April 30, 2025
Chiffre d’affaires du 1er trimestre 2025 : 166,3 M€ (+7,8%) Croissance organique : +3,5% vs T1 2024 Calendrier du dividende 2024 Paris La Défense, le 30 avril 2025 à 17h35 – Le Conseil d’administration d’Assystem S.A. (ISIN : FR0000074148 - ASY), groupe …
Press Release: Sanofi and CD&R close Opella transaction, create global consumer healthcare leader
GlobeNewswire
·
April 30, 2025
Sanofi and CD…
Communiqué de presse : Sanofi et CD&R finalisent la cession d’Opella et créent un leader mondial de la santé grand public
GlobeNewswire
·
April 30, 2025
Sanofi et CD…
Constellium Reports First Quarter 2025 Results and Maintains Full Year 2025 Guidance
GlobeNewswire
·
April 30, 2025
PARIS, April 30, 2025 (GLOBE NEWSWIRE) -- Constellium SE (NYSE: CSTM) ("Constellium" or the "Company") today reported results for the first quarter ended March 31, 2025. First quarter 2025 highlights: Shipments of 372 thousand metric tons, down 2% compared …